Legislative UpdatePart D/Prescription DrugsPrice Transparency

340B reporting mandate approved by House subcommittee, legislation moves forward

(By Ashleigh Hollowell for Becker’s hospital Review)

Legislation proposing transparency and oversight of the 340B drug discount program was passed May 17 by the House Energy and Commerce Committee’s Subcommittee on Health. The bill, H.R. 3290, will now advance to the Senate. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org

Leave a Reply